Schedule 13G ownership disclosure
ATHIRA PHARMA INC
Security class unavailable · CUSIP: 04746L104
Event date: 2023-04-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,983,668
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-23-000543
- Form type
- SC 13G
- Filer
- Athira Pharma, Inc.
- CIK
- CIK 1620463
- Filed
- Apr 20, 2023
- Reporting period
- Apr 10, 2023
- Description
- Schedule 13G beneficial ownership